SODIUM FLUORIDE F-18
Sodium Fluoride F-18 is a radioactive diagnostic tool used for PET imaging of the skeletal system. It helps healthcare providers identify and define specific areas where bone activity has changed or become irregular. Patients receive this injection to allow for detailed visualization of the bones during diagnostic scans.
How SODIUM FLUORIDE F-18 Works
This agent works by depositing fluoride F18 ions throughout the skeleton, with higher concentrations typically found in the vertebrae, pelvis, and joints. By accumulating in these areas, the drug allows for the detection of variations in bone formation and activity.
Details
- Status
- Prescription
- First Approved
- 2011-01-26
- Routes
- INTRAVENOUS
- Dosage Forms
- INJECTABLE
Companies
SODIUM FLUORIDE F-18 Approval History
What SODIUM FLUORIDE F-18 Treats
1 indicationsSODIUM FLUORIDE F-18 is approved for 1 conditions since its original approval in 2011. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Altered Osteogenic Activity
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04981509 | NCI-2021-07744 NCI-2021-07744, 22-C-0004 | Ph 2 | recruiting | Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SODIUM FLUORIDE F-18 FDA Label Details
Indications & Usage
SODIUM FLUORIDE F-18 is indicated for the treatment of Altered Osteogenic Activity.
Looking for the branded version?
FLUORINE F-18
Full clinical data, patents, trials, and competitive landscape for sodium fluoride f-18.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.